{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T01:10:55Z","timestamp":1774487455705,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2020QC083"],"award-info":[{"award-number":["ZR2020QC083"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2021QH231"],"award-info":[{"award-number":["ZR2021QH231"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2022MH058"],"award-info":[{"award-number":["ZR2022MH058"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Development Foundation of Xuzhou Medical University Affiliated Hospital","award":["XYFM202223"],"award-info":[{"award-number":["XYFM202223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00277-024-05728-6","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:02:21Z","timestamp":1711551741000},"page":"2405-2417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2\/HO-1 pathway"],"prefix":"10.1007","volume":"103","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renyu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Zang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"issue":"6","key":"5728_CR1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","volume":"111","author":"RA Kyle","year":"2008","unstructured":"Kyle RA, Rajkumar SV (2008) Multiple myeloma. Blood 111(6):2962\u20132972. https:\/\/doi.org\/10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"issue":"9","key":"5728_CR2","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/s2352-3026(22)00165-x","volume":"9","author":"J Huang","year":"2022","unstructured":"Huang J, Chan SC, Lok V, Zhang L, Lucero-Prisno DE, Xu W, Zheng Z-J, Elcarte E, Withers M, Wong MCS (2022) The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol 9(9):e670\u2013e677. https:\/\/doi.org\/10.1016\/s2352-3026(22)00165-x","journal-title":"Lancet Haematol"},{"key":"5728_CR3","doi-asserted-by":"publisher","unstructured":"Liu J, Liu W, Mi L, Zeng X, Cai C, Ma J, Wang L (2019) Incidence and mortality of multiple myeloma in China, 2006\u20132016: an analysis of the global burden of Disease Study 2016. J Hematol Oncol 12(1). https:\/\/doi.org\/10.1186\/s13045-019-0807-5","DOI":"10.1186\/s13045-019-0807-5"},{"issue":"7","key":"5728_CR4","doi-asserted-by":"publisher","first-page":"e293","DOI":"10.1016\/s1470-2045(23)00223-1","volume":"24","author":"MA Dimopoulos","year":"2023","unstructured":"Dimopoulos MA, Merlini G, Bridoux F, Leung N, Mikhael J, Harrison SJ, Kastritis E, Garderet L, Gozzetti A, van de Donk NWCJ, Weisel KC, Badros AZ, Beksac M, Hillengass J, Mohty M, Ho PJ, Ntanasis-Stathopoulos I, Mateos M-V, Richardson P, Blade J, Moreau P, San-Miguel J, Munshi N, Rajkumar SV, Durie BGM, Ludwig H, Terpos E (2023) Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group. Lancet Oncol 24(7):e293\u2013e311. https:\/\/doi.org\/10.1016\/s1470-2045(23)00223-1","journal-title":"Lancet Oncol"},{"key":"5728_CR5","doi-asserted-by":"publisher","unstructured":"De Luca F, Allegra A, Di Chio C, Previti S, Zappal\u00e0 M, Ettari R (2023) Monoclonal antibodies: the Greatest Resource to treat multiple myeloma. Int J Mol Sci 24(4). https:\/\/doi.org\/10.3390\/ijms24043136","DOI":"10.3390\/ijms24043136"},{"issue":"4","key":"5728_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1172\/jci129205","volume":"130","author":"SA Minnie","year":"2020","unstructured":"Minnie SA, Hill GR (2020) Immunotherapy of multiple myeloma. J Clin Invest 130(4):1565\u20131575. https:\/\/doi.org\/10.1172\/jci129205","journal-title":"J Clin Invest"},{"key":"5728_CR7","doi-asserted-by":"publisher","unstructured":"Mou Y, Wang J, Wu J, He D, Zhang C, Duan C, Li B (2019) Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol 12(1). https:\/\/doi.org\/10.1186\/s13045-019-0720-y","DOI":"10.1186\/s13045-019-0720-y"},{"key":"5728_CR8","doi-asserted-by":"publisher","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C (2022) Lipid peroxidation and Iron metabolism: two Corner stones in the Homeostasis Control of Ferroptosis. Int J Mol Sci 24(1). https:\/\/doi.org\/10.3390\/ijms24010449","DOI":"10.3390\/ijms24010449"},{"key":"5728_CR9","doi-asserted-by":"publisher","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R (2022) Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer 21(1). https:\/\/doi.org\/10.1186\/s12943-022-01530-y","DOI":"10.1186\/s12943-022-01530-y"},{"key":"5728_CR10","doi-asserted-by":"publisher","unstructured":"Li F-J, Long H-Z, Zhou Z-W, Luo H-Y, Xu S-G, Gao L-C (2022) System Xc\u2013\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 13. https:\/\/doi.org\/10.3389\/fphar.2022.910292","DOI":"10.3389\/fphar.2022.910292"},{"key":"5728_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","volume":"152","author":"F Ursini","year":"2020","unstructured":"Ursini F, Maiorino M (2020) Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med 152:175\u2013185. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2020.02.027","journal-title":"Free Radic Biol Med"},{"key":"5728_CR12","doi-asserted-by":"publisher","unstructured":"Casciello F, Windloch K, Gannon F, Lee JS (2015) Functional role of G9a histone methyltransferase in Cancer. Front Immunol 6. https:\/\/doi.org\/10.3389\/fimmu.2015.00487","DOI":"10.3389\/fimmu.2015.00487"},{"key":"5728_CR13","doi-asserted-by":"publisher","unstructured":"San Jos\u00e9-En\u00e9riz E, Agirre X, Rabal O, Vilas-Zornoza A, Sanchez-Arias JA, Miranda E, Ugarte A, Roa S, Paiva B, Estella-Hermoso de Mendoza A, Alvarez RM, Casares N, Segura V, Mart\u00edn-Subero JI, Ogi F-X, Soule P, Santiveri CM, Campos-Olivas R, Castellano G, de Barrena MGF, Rodriguez-Madoz JR, Garc\u00eda-Barchino MJ, Lasarte JJ, Avila MA, Martinez-Climent JA, Oyarzabal J, Prosper F (2017) Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies. Nat Commun 8(1). https:\/\/doi.org\/10.1038\/ncomms15424","DOI":"10.1038\/ncomms15424"},{"key":"5728_CR14","doi-asserted-by":"publisher","unstructured":"Zhang XY, Rajagopalan D, Chung T-H, Hooi L, Toh TB, Tian JS, Rashid MBMA, Sahib NRBM, Gu M, Lim JJ, Wang W, Chng WJ, Jha S, Chow EK-H (2020) Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma. Exp Hematol Oncol 9(1). https:\/\/doi.org\/10.1186\/s40164-020-00164-4","DOI":"10.1186\/s40164-020-00164-4"},{"issue":"7","key":"5728_CR15","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","volume":"25","author":"C Segovia","year":"2019","unstructured":"Segovia C, San Jos\u00e9-En\u00e9riz E, Munera-Maravilla E, Mart\u00ednez-Fern\u00e1ndez M, Garate L, Miranda E, Vilas-Zornoza A, Lodewijk I, Rubio C, Segrelles C, Valc\u00e1rcel LV, Rabal O, Casares N, Bernardini A, Suarez-Cabrera C, L\u00f3pez-Calder\u00f3n FF, Fortes P, Casado JA, Due\u00f1as M, Villacampa F, Lasarte JJ, Guerrero-Ramos F, de Velasco G, Oyarzabal J, Castellano D, Agirre X, Pr\u00f3sper F, Paramio JM (2019) Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression. Nat Med 25(7):1073\u20131081. https:\/\/doi.org\/10.1038\/s41591-019-0499-y","journal-title":"Nat Med"},{"key":"5728_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ejmech.2016.06.028","volume":"122","author":"SM Kondengaden","year":"2016","unstructured":"Kondengaden SM, Luo L-f, Huang K, Zhu M, Zang L, Bataba E, Wang R, Luo C, Wang B, Li KK, Wang PG (2016) Discovery of novel small molecule inhibitors of lysine methyltransferase G9a and their mechanism in leukemia cell lines. Eur J Med Chem 122:382\u2013393. https:\/\/doi.org\/10.1016\/j.ejmech.2016.06.028","journal-title":"Eur J Med Chem"},{"key":"5728_CR17","doi-asserted-by":"publisher","unstructured":"Wang Y-f, Zhang J, Su Y, Shen Y-y, Jiang D-x, Hou Y-y, Geng M-y, Ding J, Chen Y (2017) G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Nat Commun 8(1). https:\/\/doi.org\/10.1038\/s41467-017-00350-9","DOI":"10.1038\/s41467-017-00350-9"},{"issue":"1","key":"5728_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1146\/annurev-pharmtox-052220-104025","volume":"62","author":"L Torrente","year":"2022","unstructured":"Torrente L, DeNicola GM (2022) Targeting NRF2 and its downstream processes: opportunities and challenges. Annu Rev Pharmacol Toxicol 62(1):279\u2013300. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052220-104025","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5728_CR19","doi-asserted-by":"publisher","unstructured":"Caprio C, Sacco A, Giustini V, Roccaro AM (2020) Epigenetic aberrations in multiple myeloma. Cancers 12(10). https:\/\/doi.org\/10.3390\/cancers12102996","DOI":"10.3390\/cancers12102996"},{"issue":"11","key":"5728_CR20","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","volume":"19","author":"SJ Hogg","year":"2020","unstructured":"Hogg SJ, Beavis PA, Dawson MA, Johnstone RW (2020) Targeting the epigenetic regulation of antitumour immunity. Nat Rev Drug Discov 19(11):776\u2013800. https:\/\/doi.org\/10.1038\/s41573-020-0077-5","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"5728_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41573-020-00108-x","volume":"20","author":"KP Bhat","year":"2021","unstructured":"Bhat KP, \u00dcmit Kaniskan H, Jin J, Gozani O (2021) Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease. Nat Rev Drug Discovery 20(4):265\u2013286. https:\/\/doi.org\/10.1038\/s41573-020-00108-x","journal-title":"Nat Rev Drug Discovery"},{"issue":"35","key":"5728_CR22","doi-asserted-by":"publisher","first-page":"22478","DOI":"10.1021\/acsomega.1c03389","volume":"6","author":"DL Prado-Romero","year":"2021","unstructured":"Prado-Romero DL, Medina-Franco JL (2021) Advances in the exploration of the epigenetic relevant chemical space. ACS Omega 6(35):22478\u201322486. https:\/\/doi.org\/10.1021\/acsomega.1c03389","journal-title":"ACS Omega"},{"key":"5728_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","volume":"179","author":"H Cao","year":"2019","unstructured":"Cao H, Li L, Yang D, Zeng L, Yewei X, Yu B, Liao G, Chen J (2019) Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents. Eur J Med Chem 179:537\u2013546. https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.072","journal-title":"Eur J Med Chem"},{"issue":"20","key":"5728_CR24","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1158\/0008-5472.Can-10-0833","volume":"70","author":"M-W Chen","year":"2010","unstructured":"Chen M-W, Hua K-T, Kao H-J, Chi C-C, Wei L-H, Johansson G, Shiah S-G, Chen P-S, Jeng Y-M, Cheng T-Y, Lai T-C, Chang J-S, Jan Y-H, Chien M-H, Yang C-J, Huang M-S, Hsiao M, Kuo M-L (2010) H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res 70(20):7830\u20137840. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-0833","journal-title":"Cancer Res"},{"issue":"4","key":"5728_CR25","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.7150\/jca.48310","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu L, Gao X, Yang P, Sang W, Jiao J, Niu M, Liu M, Qin Y, Yan D, Song X, Sun C, Tian Y, Zhu F, Sun X, Zeng L, Li Z, Xu K (2021) EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells. J Cancer 12(4):1011\u20131022. https:\/\/doi.org\/10.7150\/jca.48310","journal-title":"J Cancer"},{"issue":"5","key":"5728_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"J Dixon Scott","year":"2012","unstructured":"Dixon Scott J, Lemberg Kathryn M, Lamprecht Michael R, Skouta R, Zaitsev Eleina M, Gleason Caroline E, Patel Darpan N, Bauer Andras J, Cantley Alexandra M, Yang Wan S, Morrison B, Stockwell Brent R (2012) Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"4","key":"5728_CR27","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22(4):266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5728_CR28","doi-asserted-by":"publisher","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR (2016) Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci 113(34). https:\/\/doi.org\/10.1073\/pnas.1603244113","DOI":"10.1073\/pnas.1603244113"},{"issue":"6","key":"5728_CR29","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35(6):830\u2013849. https:\/\/doi.org\/10.1016\/j.ccell.2019.04.002","journal-title":"Cancer Cell"},{"issue":"10","key":"5728_CR30","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1038\/s41401-023-01097-4","volume":"44","author":"L Yu","year":"2023","unstructured":"Yu L, Wang YF, Xiao J, Shen QQ, Chi SS, Gao YL, Lin DZ, Ding J, Fang YF, Chen Y (2023) Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibition. Acta Pharmacol Sin 44(10):2113\u20132124. https:\/\/doi.org\/10.1038\/s41401-023-01097-4","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"5728_CR31","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1152\/jn.00306.2022","volume":"128","author":"Y Dai","year":"2022","unstructured":"Dai Y, Hu L (2022) HSPB1 overexpression improves hypoxic-ischemic brain damage by attenuating ferroptosis in rats through promoting G6PD expression. J Neurophysiol 128(6):1507\u20131517. https:\/\/doi.org\/10.1152\/jn.00306.2022","journal-title":"J Neurophysiol"},{"key":"5728_CR32","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.2147\/ott.S254995","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Li Y, Zhang R, Wang F, Wang T, Jiao Y (2020) The role of erastin in ferroptosis and its prospects in cancer therapy. OncoTargets Therapy 13:5429\u20135441. https:\/\/doi.org\/10.2147\/ott.S254995","journal-title":"OncoTargets Therapy"},{"key":"5728_CR33","doi-asserted-by":"publisher","unstructured":"Zhong Y, Tian F, Ma H, Wang H, Yang W, Liu Z, Liao A (2020) FTY720 induces ferroptosis and autophagy via PP2A\/AMPK pathway in multiple myeloma cells. Life Sci 260. https:\/\/doi.org\/10.1016\/j.lfs.2020.118077","DOI":"10.1016\/j.lfs.2020.118077"},{"issue":"15","key":"5728_CR34","doi-asserted-by":"publisher","first-page":"4474","DOI":"10.7150\/ijbs.62236","volume":"17","author":"A Ali","year":"2021","unstructured":"Ali A, Shafarin J, Unnikannan H, Al-Jabi N, Jabal RA, Bajbouj K, Muhammad JS, Hamad M (2021) Co-targeting BET bromodomain BRD4 and RAC1 suppresses growth, stemness and tumorigenesis by disrupting the c-MYC-G9a-FTH1axis and downregulation of HDAC1 in molecular subtypes of breast cancer. Int J Biol Sci 17(15):4474\u20134492. https:\/\/doi.org\/10.7150\/ijbs.62236","journal-title":"Int J Biol Sci"},{"key":"5728_CR35","doi-asserted-by":"publisher","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23. https:\/\/doi.org\/10.1016\/j.redox.2019.101107","DOI":"10.1016\/j.redox.2019.101107"},{"issue":"17","key":"5728_CR36","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1089\/ars.2017.7176","volume":"29","author":"MJ Kerins","year":"2018","unstructured":"Kerins MJ, Ooi A (2018) The roles of NRF2 in modulating cellular iron homeostasis. Antioxid Redox Signal 29(17):1756\u20131773. https:\/\/doi.org\/10.1089\/ars.2017.7176","journal-title":"Antioxid Redox Signal"},{"key":"5728_CR37","doi-asserted-by":"publisher","unstructured":"Hill KS, McDowell A, McCorkle JR, Schuler E, Ellingson SR, Plattner R, Kolesar JM (2021) KEAP1 is required for artesunate anticancer activity in non-small-cell lung cancer. Cancers 13(8). https:\/\/doi.org\/10.3390\/cancers13081885","DOI":"10.3390\/cancers13081885"},{"key":"5728_CR38","doi-asserted-by":"publisher","unstructured":"Zhao J, Chen Y, Xiong T, Han S, Li C, He Y, He Y, Zhao G, Wang T, Wang L, Cheng T, Wang C, Wang J (2023) Clustered cobalt nanodots initiate ferroptosis by upregulating heme oxygenase 1 for radiotherapy sensitization. Small 19(10). https:\/\/doi.org\/10.1002\/smll.202206415","DOI":"10.1002\/smll.202206415"},{"key":"5728_CR39","doi-asserted-by":"publisher","unstructured":"Jang JE, Eom J-I, Jeung H-K, Chung H, Kim YR, Kim JS, Cheong J-W, Min YH (2020) PERK\/NRF2 and autophagy form a resistance mechanism against G9a inhibition in leukemia stem cells. J Exp Clin Cancer Res 39(1). https:\/\/doi.org\/10.1186\/s13046-020-01565-3","DOI":"10.1186\/s13046-020-01565-3"},{"key":"5728_CR40","doi-asserted-by":"publisher","unstructured":"Jin T, Chen C (2022) Umbelliferone delays the progression of diabetic nephropathy by inhibiting ferroptosis through activation of the Nrf-2\/HO-1 pathway. Food Chem Toxicol 163. https:\/\/doi.org\/10.1016\/j.fct.2022.112892","DOI":"10.1016\/j.fct.2022.112892"},{"key":"5728_CR41","doi-asserted-by":"publisher","unstructured":"Yang J, Mo J, Dai J, Ye C, Cen W, Zheng X, Jiang L, Ye L (2021) Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2\/HO-1 signalling pathway in KRAS mutant colorectal cancer. Cell Death Dis 12(11). https:\/\/doi.org\/10.1038\/s41419-021-04367-3","DOI":"10.1038\/s41419-021-04367-3"},{"key":"5728_CR42","doi-asserted-by":"publisher","unstructured":"Xu Y, Li Y, Li J, Chen W (2022) Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation. Redox Biol 53. https:\/\/doi.org\/10.1016\/j.redox.2022.102349","DOI":"10.1016\/j.redox.2022.102349"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05728-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T12:05:27Z","timestamp":1720094727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["5728"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05728-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3912123\/v1","asserted-by":"object"}]},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"31 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}